Skip to content
Live Market Feed
VILINBIO
₹47.70
▲ +4.96%
·
NIFTY 50
23,405.60
▼ -0.33%
·
SENSEX
74,346.17
▼ -0.41%
·
NIFTY PHARMA
24,086.60
▲ +0.33%
·
52W HIGH
₹54.40
·
52W LOW
₹18.95
·
P/E RATIO
310.3x
·
VILINBIO
₹47.70
▲ +4.96%
·
NIFTY 50
23,405.60
▼ -0.33%
·
SENSEX
74,346.17
▼ -0.41%
·
NIFTY PHARMA
24,086.60
▲ +0.33%
·
52W HIGH
₹54.40
·
52W LOW
₹18.95
·
P/E RATIO
310.3x
NSE: VILINBIO
LIVE FEED
Home
About Us
Corporate Ethos
Management
Investors
Financial Information
Annual General Meeting
Extra-Ordinary General Meeting
Annual Reports and Annual Returns
Board Meeting
IPO Documents
Shareholding Pattern
Corporate Governance
Policies
Compliances
Investor Grievance
Board committees & Board members
Open Offer
Scheme of Amalgamation by Absorption
Products
CARDIOVASCULAR DRUGS
MUSCULO-SKELETAL DRUGS
ANTIBIOTICS DRUGS
RESPIRATORY SYSTEM & ANTI-ALLERGICS DRUGS
GENITO-URINARY TRACT DRUGS
ALIMENTARY SYTEM DRUGS
CENTRAL NERVOUS SYSTEM DRUGS
MULTI-VITAMINS,MINERALS & AMINO ACIDS SUPPLEMENTS
ANTI DIABETIC DRUGS
RESPIRATORY SYSTEM & ANTI-ALLERGICS DRUGS
MISCELLANEOUS DRUGS
LIQUID ORALS
EXTERANAL PREPARATIONS
Group Entities
Vilin Bio Roorkee Plant
Oncology API Plant
Vilin Bio Med Inc, USA
Vilin Bio Med Limited Jamaica
Vilin Biotherapeutics R&D
Business Segments
Regulatory Affairs
Research and Development
Manufacturing
Cosmetics
Food and Neutra
Careers
Updates
Contact Us
Search for:
Search
Search
Home
About Us
Corporate Ethos
Management
Investors
Financial Information
Annual General Meeting
Extra-Ordinary General Meeting
Annual Reports and Annual Returns
Board Meeting
IPO Documents
Shareholding Pattern
Corporate Governance
Policies
Compliances
Investor Grievance
Board committees & Board members
Open Offer
Scheme of Amalgamation by Absorption
Products
CARDIOVASCULAR DRUGS
MUSCULO-SKELETAL DRUGS
ANTIBIOTICS DRUGS
RESPIRATORY SYSTEM & ANTI-ALLERGICS DRUGS
GENITO-URINARY TRACT DRUGS
ALIMENTARY SYTEM DRUGS
CENTRAL NERVOUS SYSTEM DRUGS
MULTI-VITAMINS,MINERALS & AMINO ACIDS SUPPLEMENTS
ANTI DIABETIC DRUGS
RESPIRATORY SYSTEM & ANTI-ALLERGICS DRUGS
MISCELLANEOUS DRUGS
LIQUID ORALS
EXTERANAL PREPARATIONS
Group Entities
Vilin Bio Roorkee Plant
Oncology API Plant
Vilin Bio Med Inc, USA
Vilin Bio Med Limited Jamaica
Vilin Biotherapeutics R&D
Business Segments
Regulatory Affairs
Research and Development
Manufacturing
Cosmetics
Food and Neutra
Careers
Updates
Contact Us
Eighteenth Annual General Meeting
Eighteenth Annual General Meeting-Video Recording
Scrutinizer Report
Outcome of 21.09.2024
×
No WhatsApp Number Found!
WhatsApp us